VCYT
VCYT
NASDAQ · Biotechnology

Veracyte Inc

$23.69
-28.83 (-54.89%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Buy 16 84%
Hold 2 11%
Sell 1 5%
Price Target
Analyst Price Target +97.8% upside
Low Target $30.44
Average Target $46.85
High Target $57.64
Current Price $23.69
Current
$23.69
Target
$46.85
$30.44 $46.85 avg $57.64
Scenario Analysis
Bear Case
$30.44
28.5%
Low target
Base Case
$46.85
+97.8%
Avg target
Bull Case
$57.64
+143.3%
High target
Risk/Reward
5.0x
Highly favorable
Price in Context
52-Week High
$60.91
-61.1% from high
52-Week Low
$29.46
+-19.6% from low
50-Day SMA
$44.90
-47.2% vs SMA
200-Day SMA
$42.96
-44.9% vs SMA
RSI (14)
73.4
Overbought
Target vs 52W High
$46.85
-23.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
Hold 42 43% $190.87 -58.6%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +115.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
Hold 31 35% $149.45 -42.4%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
Strong Buy 30 90% $142.91 -54.4%
RVMD
Revolution Medicines Inc
Strong Buy 29 93% $114.11 -40.8%